Posts

Showing posts with the label Drug Device Combination Market Share

Growing Demand in North America, Europe to Drive Drug Device Combination Market by Size, Share, Global Scope, Sales Revenue, Emerging Trends and Global Forecast to 2023

Market Highlights: The global drug device combination market is expected to exhibit a strong 11.4% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a comprehensive picture of the global drug device combination market in terms of the historical growth figures of the market and the major drivers and restraints acting on the market and influencing its growth path. The global drug device combination market is mainly driven by the increasing awareness about the efficacy of drug device combinations. Drug device combinations are used when either alone is not effective enough, or when a combination presents the best chance of recovery. Diseases such as tachycardia and coronary concerns show an improved recovery rate when treated with drug device combinations. Access Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/drug-device-combination-market-6946...

Drug Device Combination Market is Expected to Record a Successive Double-Digit CAGR of 11.4% During Forecast 2018-2023

Market Highlights: The global drug-device combination market is expected to grow at an approximate CAGR of 11.4% during the forecast period, 2018–2023. Drug-device combination is the combination of drugs and various medical devices that can be chemically/physically assembled as separate or cross labeled products.  Factors such as the increasing global burden of the diseases like cardiovascular diseases, urology diseases followed by growing healthcare expenditure, rising awareness for the market products drives the market growth. However, high cost of the products and related side effects, and presence of low income countries within the developing regions restricts the market to grow during the forecast period. The factsheet of 2017 published by the Centers for Disease Control and Prevention stated that ~ 30 million people, accounting for 15.0% of U.S. adults population suffer from chronic kidney diseases (CKD). However, high cost of the products and therapeutics related s...